Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.

Discover how resolving MRI-detected inflammation improves clinical outcomes for aptients with axial spondyloarthritis.

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Coherus Biosciences (CHRS – Research Report), with a price ...

The newer biologics — interleukin (IL)-17, IL-12/23, and IL-23 inhibitors — have cardiovascular safety profiles comparable with those of tumor necrosis factor (TNF) inhibitors in biologic ...

Right first digit, pre-treatment (left) and after 60 days (2 infiltrations), 1 infiltration every 30 days (right) Connective Tissue Disease Unit, Dermatology Service, Universidade de Santo Amaro, São ...